BIIB34:BVMF
Biogen Inc BDR
၁၈၆.၀၁ R$
၀.၀၀%
(၀.၀၀) 1D
အောက် ၉, GMT-၃ ၁၆:၅၆:၀၀ · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BIIB34...
Open
၁၈၆.၀၁ R$
High
၁၈၆.၀၁ R$
Low
၁၈၆.၀၁ R$
Mkt. cap
ဋေ ၃.၃၃ ထ
Avg. vol.
၇.၀၀
Volume
၁.၀၀
52-wk high
၁၉၁.၀၀ R$
52-wk low
၁၂၈.၆၉ R$
Shares outstanding
၁၄.၇၈ ကုဋေ
No. of employees
၈ ထောင်
Open
၁၈၆.၀၁ R$
High
၁၈၆.၀၁ R$
Low
၁၈၆.၀၁ R$
Mkt. cap
ဋေ ၃.၃၃ ထ
Avg. vol.
၇.၀၀
Volume
၁.၀၀
52-wk high
၁၉၁.၀၀ R$
52-wk low
၁၂၈.၆၉ R$
Shares outstanding
၁၄.၇၈ ကုဋေ
No. of employees
၈ ထောင်
News stories
From web sources and news partners
GuruFocus
·
ပြီးခဲ့သည့် ၂ ရက်
Biogen Inc (BIIB) Shares Surge 3.3% -- What GF Score of 73 Tells Investors
Profile
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the treatment of neurological diseases. The company's primary products are dimethyl fumarate, diroximel fumarate, interferon beta-1a, peginterferon beta-1a, and natalizumab, all for the treatment of multiple sclerosis; nusinersen for the treatment of spinal muscular atrophy; omaveloxolone for the treatment of Friedreich's ataxia; tofersen for the treatment of ALS; and dimethyl fumarate for the treatment of severe plaque psoriasis. The company also produces 5 biosimilars and has collaborations with Genentech for several drugs.
The company is ranked 424th on the Fortune 500 and 845th on the Forbes Global 2000. Wikipedia
About Biogen Inc BDR
CEOChris Viehbacher
Employees၇.၅ ထောင်
Founded၁၉၇၈
Headquartersကင်းဘရစ်ချ်, မက်ဆာချူးဆက်ပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websitebiogen.com